BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

A head-to-head comparison of vascular closure devices defied expectations in the CHOICE-CLOSURE trial. For large-bore arterial access site closure after transfemoral transcatheter aortic valve ...

CHICAGO, IL–Use of a large-bore vascular closure device tested in patients undergoing transcatheter aortic valve replacement and endovascular aortic repair procedures appears to be safe and effective ...

WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...

Kensey Nash originally developed Angio-Seal, and St. Jude bought the marketing and manufacturing rights for the device from Tyco International in early 1999. "Angio-Seal will now be marketed by one of ...

InSeal Medical won a CE mark for its vascular closure device, used to seal large bores left by catheter-based procedures, such as transcatheter aortic valve replacement (TAVR). The InClosure VCD ...